0 NYSE Companies - November 26, 2018K4Connect Selects Ooma Enterprise To Boost Call Center Efficiency and ResponsivenessSUNNYVALE, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) — Ooma, Inc., a smart communications platform for businesses and consumers, today announced […]Read More
0 NYSE Companies - November 26, 2018Sysco Reports Progress of “Delivering A Better Tomorrow” in 2018 Corporate Social Responsibility ReportHOUSTON, Nov. 26, 2018 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY), the leading global foodservice distribution company, today released its […]Read More
0 NASDAQ Companies - November 26, 2018Yulong Eco-Materials Limited Announces Results of Special Shareholders Meeting Held in Bangkok, Thailand on November 26, 2018New York and Bangkok, Thailand, Nov. 26, 2018 (GLOBE NEWSWIRE) — Yulong Eco-Materials Limited (Nasdaq: YECO) (“Yulong” or the “Company”), hereby […]Read More
0 NASDAQ Companies - November 26, 2018Nuance’s AI Marketplace Delivers AI at Scale with Industry’s First Workflow-Integrated Market for Diagnostic Imaging AlgorithmsCollaborative community of developers, publishers, data scientists, and radiologists can seamlessly create, distribute, and utilize continuously learning algorithms for 25,000 […]Read More
0 NASDAQ Companies - November 26, 2018SeaChange International to Issue Fiscal 2019 Third Quarter Results on December 10, 2018ACTON, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) — SeaChange International, Inc. (NASDAQ: SEAC) will announce its fiscal 2019 third quarter […]Read More
0 NASDAQ Companies - November 26, 2018Kratos Receives $4.7 Million in C5ISR Program AwardsSAN DIEGO, Nov. 26, 2018 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security […]Read More
0 NASDAQ Companies - November 26, 2018Zogenix to Announce New Data at 72nd American Epilepsy Society Annual MeetingFull Results from Second Pivotal Phase 3 Trial of FINTEPLA® (ZX008) in Dravet Syndrome (Study 1504) New Long-Term Efficacy and […]Read More
0 NASDAQ Companies - November 26, 2018Evelo Biosciences Announces First Dosing in Phase 1b Clinical Trial of EDP1815 in Psoriasis and Atopic DermatitisData Expected in Second Half of 2019 CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (NASDAQ:EVLO) (“Evelo”) […]Read More
0 NASDAQ Companies - November 26, 2018Highway Holdings Reports Fiscal 2019 Second Quarter ResultsHONG KONG, Nov. 26, 2018 (GLOBE NEWSWIRE) — Highway Holdings Limited (Nasdaq: HIHO) today reported results for its fiscal 2019 […]Read More
0 NASDAQ Companies - November 26, 2018Axovant Stengthens Team with Additional Expertise to Support Gene Therapy PipelineGreg MacMichael, Ph.D., formerly global head of cell and gene therapy technical development and manufacturing at Novartis, joins Axovant as […]Read More